187 results
8-K
EX-99.1
MDXG
Mimedx Group Inc
30 Apr 24
MIMEDX Announces First Quarter 2024 Operating and Financial
4:10pm
Strategic and other expenses
Expenses related to disbanding of Regenerative Medicine business unit
Adjusted EBITDA margin
First Quarter 2024 Results … ” and exclude the historical costs of the Regenerative Medicine business unit, which was disbanded beginning in June 2023. For a full discussion of the impact
8-K
EX-99.1
MDXG
Mimedx Group Inc
28 Feb 24
MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results
4:22pm
of Regenerative Medicine business unit
Reorganization expenses
Adjusted EBITDA margin
24.4
9.8
18.2
2.6
Fourth Quarter and Full Year 2023 Results … of the Company’s fourth quarter and full year 2023 results are made on a “continuing operations basis” and exclude the historical costs of the Regenerative
8-K
EX-99.2
uvd79qyxko421 i1y
13 Nov 23
MIMEDX to Participate in Upcoming Investor Conferences
8:14am
8-K
EX-99.1
tlehxxeo3tez36twa
30 Oct 23
MIMEDX Announces Third Quarter 2023 Operating and Financial Results
4:05pm
8-K
EX-99.2
j67azw8mzmyxx
5 Sep 23
MIMEDX to Present at Upcoming Investor Conferences
8:38am
8-K
EX-99.1
n70gikhumoieedfg9e8q
1 Aug 23
MIMEDX Announces Second Quarter 2023 Operating and Financial Results
4:03pm
8-K
EX-99.2
4cvstyba8 3xjy
1 Aug 23
MIMEDX Announces Second Quarter 2023 Operating and Financial Results
4:03pm
8-K
EX-99.1
f6jx ibqvebbqs
20 Jun 23
Departure of Directors or Certain Officers
4:03pm
8-K
EX-99.2
nbct lii445
20 Jun 23
Departure of Directors or Certain Officers
4:03pm
8-K
elk8f5np5 axp6
20 Jun 23
Departure of Directors or Certain Officers
4:03pm